达帕格列嗪
医学
2型糖尿病
回顾性队列研究
糖尿病
内科学
期限（时间）
二甲双胍
内分泌学
重症监护医学
量子力学
物理
作者
Mario Luca Morieri,Itamar Raz,Agostino Consoli,Mauro Rigato,Annunziata Lapolla,Fabio Broglio,Enzo Bonora,Angelo Avogaro,Gian Paolo Fadini,for the DARWIN-FUP network,Federica Ginestra,Gloria Formoso,Agostino Consoli,Francesco Andreozzi,Giorgio Sesti,Salvatore Turco,Luigi Lucibelli,A Gatti,Raffaella Aldigeri,Alessandra Dei
标识
DOI：10.1007/s40618-022-02002-2
摘要
Elderly patients with T2D initiating dapagliflozin had a lower probability of achieving individualized HbA1c targets than those initiating DPP-4 inhibitors but displayed better improvements in extra-glycaemic endpoints.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
菜菜菜
cdercder
Nole
GingerF
Criminology34
馨馨的科科
潇洒的惋清
无极微光
平淡的梦菲
乐空思
heekkll
活雷锋
你嵙这个期刊没买
cherry
伶俐书芹
mafukairi
怡然的凌兰
XX
轻松骁
初景
皖公网安备34019202002308
